What is it about?
Using national hospital data for England and a survey of orthopaedic surgeons, we assessed the relation between different choices of blood clot prevention medication on post-operative complications.
Featured Image
Why is it important?
The newer drugs are expensive and not supported by much evidence of superiority over older ones. We found no benefit and agree that the choice should be left to the individual surgeon.
Read the Original
This page is a summary of: The effect of new oral anticoagulants and extended thromboprophylaxis policy on hip and knee arthroplasty outcomes: observational study, Arthroplasty Today, June 2015, Elsevier,
DOI: 10.1016/j.artd.2015.03.004.
You can read the full text:
Contributors
The following have contributed to this page
